AI assistant
Sending…
FENNEC PHARMACEUTICALS INC. — Director's Dealing 2025
Aug 1, 2025
35599_dirs_2025-08-01_acba5a26-e1db-4281-b601-a5d56456a657.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: FENNEC PHARMACEUTICALS INC. (FENC)
CIK: 0001211583
Period of Report: 2025-07-31
Reporting Person: Raykov Rosty (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-07-31 | Common shares | A | 5208 | — | Acquired | 65878 | Direct |
Footnotes
F1: Represents shares released from restriction from shares awarded 3/31/2023 and 5/16/2024.
More from FENNEC PHARMACEUTICALS INC.
Regulatory Filings
2026
May 22
Regulatory Filings
2026
May 18
Interim / Quarterly Report
2026
May 14
Regulatory Filings
2026
Apr 28
Regulatory Filings
2026
Apr 7
Annual Report
2026
Mar 27
Regulatory Filings
2026
Mar 24
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Regulatory Filings
2026
Feb 20